Alpern Robert J — SEC Form 4 filings
SEC reporting owner CIK 1448074. 22 Form 4 filings on record with FilingPulse; latest filed 2026-04-02.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2024-04-02 to 2026-04-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | Director | 11 | — | — | 11 |
| AbbVie Inc. (ABBV) | Director | 11 | — | — | 11 |
Form 4 filings — Alpern Robert J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 35 (derivative) @ $217.49 | EDGAR |
| 2026-04-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 76 (derivative) @ $102.67 | EDGAR |
| 2026-01-05 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 34 (derivative) @ $228.49 | EDGAR |
| 2026-01-05 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 62 (derivative) @ $125.29 | EDGAR |
| 2025-10-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 58 (derivative) @ $133.94 | EDGAR |
| 2025-10-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 33 (derivative) @ $231.54 | EDGAR |
| 2025-07-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 40 (derivative) @ $185.62 | EDGAR |
| 2025-07-01 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 57 (derivative) @ $136.01 | EDGAR |
| 2025-05-13 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,203 @ $0 | EDGAR |
| 2025-04-29 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 1,635 @ $0 | EDGAR |
| 2025-04-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 35 (derivative) @ $209.52 | EDGAR |
| 2025-04-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 59 (derivative) @ $132.65 | EDGAR |
| 2025-01-03 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 42 (derivative) @ $177.70 | EDGAR |
| 2025-01-03 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 69 (derivative) @ $113.11 | EDGAR |
| 2024-10-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 37 (derivative) @ $197.48 | EDGAR |
| 2024-10-01 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 69 (derivative) @ $114.01 | EDGAR |
| 2024-07-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 43 (derivative) @ $171.52 | EDGAR |
| 2024-07-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 75 (derivative) @ $103.91 | EDGAR |
| 2024-05-07 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,322 @ $0 | EDGAR |
| 2024-04-30 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 1,866 @ $0 | EDGAR |
| 2024-04-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 41 (derivative) @ $182.10 | EDGAR |
| 2024-04-02 | 4 | ABBOTT LABORATORIES (ABT) | Grant/award (A): 69 (derivative) @ $113.66 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1448074 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →